Real life effectiveness of initiation of basal insulin in type 2 insulin naive diabetic patients: Giargine vs. Nph vs. detemir

被引:0
|
作者
Sharplin, Peter
Mehin, Nazanin
Mcewan, Phil
Tetlow, Tony
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A658 / A659
页数:2
相关论文
共 50 条
  • [1] Intensified insulin therapy of type 2 diabetes mellitus: Insulin glargine vs. insulin detemir as basal insulin
    Jungmann, Eckart
    DIABETES, 2006, 55 : A118 - A118
  • [2] Comparing efficiency of insulin glargine vs. NPH insulin in patients with type 2 diabetes
    Kodela, B.
    Petrovic, J.
    Velickovic-Radovanovic, R.
    Lilic, R.
    Radenkovic, S.
    Dedovic, I
    VALUE IN HEALTH, 2007, 10 (06) : A254 - A254
  • [3] Insulin Detemir vs. NPH: Association with Maternal Weight Gain in Pregnancy
    Herrera, Kimberly
    Rosenn, Barak
    Foroutan, Janelle
    Bimson, Brianne
    Al-Ibraheemi, Zainab
    Scarpelli, Sophia
    Brustman, Lois
    DIABETES, 2015, 64 : A675 - A675
  • [4] BIPHASIC INSULIN ASPART 30 VS. NPH PLUS REGULAR HUMAN INSULIN IN TYPE 2 DIABETIC PATIENTS: A COST-EFFECTIVENESS STUDY
    Farshchi, A.
    Oskuee, M.
    Rashed, M.
    Aghili, R.
    Kebriaeezadeh, A.
    Esteghamati, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A90 - A91
  • [5] Self-reported impressions of insulin detemir among patients with type 2 diabetes: Insulin-naive vs. prior insulin users
    Kerney, Donna L.
    Paradis, Diana
    Lucrezia, Laurel
    Brunton, Stephen
    DIABETES, 2007, 56 : A537 - A537
  • [6] Basal Insulin Initiation in Primary vs. Specialist Care
    Orozco-Beltran, Domingo
    Pan, Chang Yu
    Svendsen, Anne Louise
    Faerch, Louise
    Caputo, Salvatore
    DIABETES, 2014, 63 : A84 - A84
  • [7] Therapy in type 2 diabetes: Insulin glargine vs. 2 NPH insulin both in combination with glimepiride
    Eliaschewitz, FG
    Calvo, C
    Valbuena, H
    Ruiz, M
    Aschner, P
    Villena, J
    Ramirez, LA
    Jimenez, J
    ARCHIVES OF MEDICAL RESEARCH, 2006, 37 (04) : 495 - 501
  • [8] Biphasic insulin Aspart 30 vs. NPH plus regular human insulin in type 2 diabetes patients; a cost-effectiveness study
    Amir Farshchi
    Rokhsareh Aghili
    Maryam Oskuee
    Marjan Rashed
    Sina Noshad
    Abbas Kebriaeezadeh
    Maryam Kia
    Alireza Esteghamati
    BMC Endocrine Disorders, 16
  • [9] Biphasic insulin Aspart 30 vs. NPH plus regular human insulin in type 2 diabetes patients; a cost-effectiveness study
    Farshchi, Amir
    Aghili, Rokhsareh
    Oskuee, Maryam
    Rashed, Marjan
    Noshad, Sina
    Kebriaeezadeh, Abbas
    Kia, Maryam
    Esteghamati, Alireza
    BMC ENDOCRINE DISORDERS, 2016, 16
  • [10] Safety and efficacy of insulin detemir vs. insulin NPH in pregnant women with diabetes: a systematic review and meta-analysis
    Fatima, Kaneez
    Siddiqi, Ahmed K.
    Shakil, Saad
    Akhtar, Sareema E.
    Quraishy, Maryam S.
    Siddiqui, Khadija
    Rafique, Esha
    Maniya, Muhammad T.
    MINERVA OBSTETRICS AND GYNECOLOGY, 2024, 76 (06) : 578 - 589